PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals Accelerate Lumbar Fusion
NTAP provides additional Medicare reimbursement to hospitals using PearlMatrix, the first and only bone growth accelerator demonstrating superior lumbar fusion speed WESTMINSTER, Colo., Oct. 1, 2026 /PRNewswire/ -- Cerapedics Inc., a commercial-stage musculoskeletal company dedicated to...
Covered in this story
Analyst targets on NetApp
- Barclays: $204 → $219 by Oct 2027 · Equal Weight via Seeking Alpha
- Goldman Sachs: $185 → $210 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $NTAP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NetApp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.